CLINICAL ROLE -
New Radiation Approach Improves Breast Cancer Treatment
More than 3000 patients with breast cancer have received radiation with the Xoft System.
Read More
Obesity, Overweight Causes Early Onset Cardiovascular Disease
Patients with obesity developed heart disease 4.3 years earlier.
Unhealthy Food Responsible for Hundreds of Thousands of Deaths Per Year
Unhealthy eating habits involved with more than 400,000 deaths in 2014.
Human Protein May Prevent Castration-Resistant Prostate Cancer
Treatment with endostatin slowed the proliferation of resistant prostate cancer cells.
FDA Accepts Application for Rare Neuromuscular Disorder Drug
Eculizumab (Soliris) can reduce disease burden for patients with refractory generalized myasthenia gravis.
Trending News Today: New Two-Dose Recommendation of HPV Vaccine Could Increase Uptake
Top news of the day from across the health care landscape.
Application for Rare Neuromuscular Disorder Drug Accepted by FDA
Soliris treats patients with refractory generalized myasthenia gravis.
Repurposed Diabetes Drug Shows Promise as Breast Cancer Treatment
Epalrestat could prevent metastasis in patients with basal-like triple-negative breast cancer.
Soy Consumption Could Lower Mortality Among Breast Cancer Patients
High consumption of isoflavones reduced all-cause mortality in patients with breast cancer by 21%.
Diabetes Drug Shows Promise Treating Breast Cancer
Repurposed drugs may provide new therapies for cancer.
How Does Soy Consumption Impact Breast Cancer Outcomes?
Isoflavone supplements may influence outcomes among patients with breast cancer.
Trending News Today: Republicans Divided on How to Move Forward After AHCA Failure
Top news of the day from across the healthcare landscape.
FDA Approves Zejula for Maintenance Treatment of Cancer
The FDA has approved Tesaro’s Zejula (niraparib) for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
FDA Approves Ovarian Cancer Drug
Niraparib (Zejula) FDA approved to treat epithelial ovarian, fallopian tube, or primary peritoneal cancers.
Niraparib Approved to Treat Ovarian Cancer
FDA approves Zejula for the maintenance treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancers.
Diversity of profession to be focus of World Pharmacists Day 2017
“From research to health care: Your pharmacist is at your service” is the theme of this year’s World Pharmacists Day on 25 September, the International Pharmaceutical Federation (FIP) announced today.
Four Reasons Why Specialty Pharmacies Fail
There is little room for error in the highly competitive specialty pharmacy landscape.
Physicians Receiving Gifts from Pharmaceutical Industry More Likely to Prescribe Branded Drugs
Only 5% of patients knew their physician had received payments from a pharmaceutical or medical device company.
Study of How the Brain Repairs Damage May Lead to New Multiple Sclerosis Treatments
Findings open the door for new therapeutic options for myelin regeneration in multiple sclerosis.
Investigational Drug May Regenerate Tissue Following Heart Attack
MSI-1436 reduced the size of scar tissue post-heart attack by 53% in mouse models.
Antibody-Based Drug Delivery Method Effective in Hard-to-Treat Cancers
Most models were cancer-free within 6 weeks of treatment with selenomab-drug conjugates.
Gestational Diabetes May Increase Risk of Metabolic Disease in Children
Children born to mothers with gestational diabetes have altered fat cells.
Antibody-drug Conjugates Show Promise in Hard-to-Treat Cancers
Next-generation antibody treatments effectively deliver cytotoxic drugs to tumors.
Equine Therapy Improves Outcomes in Patients with Neuromuscular Disorders
Equine-assisted therapy improved motor function in cerebral palsy and multiple sclerosis.
Rheumatoid Arthritis Drug Market Will Reach Nearly $30 Billion by 2025
New report reveals trends in the 8 major markets over the next decade.
Higher-Spending Physicians Not Linked to Better Patient Outcomes
Higher physician spending does not equal better outcomes for hospitalized patients.
Trending News Today: Lawmakers Call for Bipartisanship to Fix ACA
Trending News Today: AHCA Defeat Could Delay Healthcare Reform into Future
How Pharmacy Advocacy Can Improve Patient Outcomes
Pharmacists can address barriers to treatment, engage with patients, and advocate for change at the community and federal levels.
Immunotherapy Boosts Treatment of Castration-Resistant Prostate Cancer
Corticosteroids, chemotherapy, and immunotherapy may all be used to treat castration-resistant prostate cancer.
